CellBion Co., Ltd. (KOSDAQ:308430)

South Korea · Delayed Price · Currency is KRW

27,700

-50 (-0.18%)

At close: Feb 27, 2026

Revenue by Segment

Financials in millions KRW. Fiscal year is January - December.

Millions KRW. Fiscal year is Jan - Dec.

Fiscal Year	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018	FY 2017	FY 2016
Period Ending	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020	Dec '19 Dec 31, 2019	Dec '18 Dec 31, 2018	Dec '17 Dec 31, 2017	Dec '16 Dec 31, 2016
Pharmaceuticals		1.76B	916.88M	1.36B	349.95M
Pharmaceuticals Growth		92.27%	-32.61%	288.80%	-
Total		1.76B	916.88M	1.36B	349.95M
Total Growth		92.27%	-32.61%	288.80%	-

Revenue by Geography

Financials in millions KRW. Fiscal year is January - December.

Millions KRW. Fiscal year is Jan - Dec.

Fiscal Year	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018	FY 2017	FY 2016
Period Ending	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020	Dec '19 Dec 31, 2019	Dec '18 Dec 31, 2018	Dec '17 Dec 31, 2017	Dec '16 Dec 31, 2016
South Korea		1.76B	916.88M	1.36B	349.95M
South Korea Growth		92.27%	-32.61%	288.80%	-
Total		1.76B	916.88M	1.36B	349.95M
Total Growth		92.27%	-32.61%	288.80%	-

Source: S&P Global Market Intelligence.